Company / EPS (Diluted)
Doximity EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.53
FY2025
5-year range
$0.13 / $0.70
FY2021-FY2025
Trend
-24.3%
vs FY2024
Sector context
#82 of 159
Health Care
What the data says
At $0.53, Doximity's eps (diluted) ranks #82 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 7 years, ranging from $0.13 in FY2022 to $0.70 in FY2024.
Based on SEC 10-K filings.
0.53 in FY2025 with a 5-year CAGR of +18.2%.
Improved from $0.23 to $0.53 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +59.8%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Sector benchmark
#82 of 159 in Health CareTop 52% of 159This company $0.53 Sector average $1.66
▼
-68.0% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 24.3% year-over-year.
- Ranks #82 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.53 | -24.3% |
| FY2024 | $0.70 | +204.3% |
| FY2023 | $0.23 | +76.9% |
| FY2022 | $0.13 | -81.4% |
| FY2021 | $0.70 | +204.3% |
| FY2020 | $0.23 | +76.9% |
| FY2019 | $0.13 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026